Sumitomo Mitsui Trust Holdings, Inc. Crispr Therapeutics Ag Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,539,889 shares of CRSP stock, worth $96.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,539,889
Previous 2,745,676
7.49%
Holding current value
$96.2 Million
Previous $108 Million
20.02%
% of portfolio
0.06%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding CRSP
# of Institutions
483Shares Held
63.9MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$340 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$331 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$144 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$105 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$104 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.95B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....